NASDAQ: EXAS 90.79
-1.42 -1.54% Minimum 20 min delay
9:49 AM ET on Apr 22, 2019
Volume: 164,329
NASDAQ: EXAS 90.79
-1.42 -1.54% Minimum 20 min delay
9:49 AM ET on Apr 22, 2019
Volume: 164,329

OUR FIRST MISSION:

To work with patients, payers & providers to help play a role in the eradication of colorectal cancer.

Exact Sciences Laboratories

How our lab’s technologies and efficiencies carry Cologuard from arrival to result.

The Exact Science of Customer Care

Supporting patients and driving compliance is a science all its own. Learn how we practice it.

Tennis Anyone?

How Cologuard's keeping Steve Rubin on the court and bringing physicians into play.

Latest Financial Reports

Current Corporate Presentation

Corporate First Quarter 2019 Presentation March 14, 2019
Download (PDF 1.96 MB)